$1.21
-0.11-8.33%
Last update: Oct 30, 9:29 AM
Virax Biolabs Group Ltd (VRAX) Stock Price, Quote, News & History
VRAXNASDAQ
Dow Jones up 0.1% on Friday with NASDAQ and S&P 500 also rising. Communication services shares jumped 0.9% while health care fell 0.5%. Simulations Plus Inc...
You can purchase shares of Virax Biolabs Group (NASDAQ:VRAX) through any online brokerage.
Other companies in Virax Biolabs Group’s space includes: McKesson Corp (NYSE:MCK), Cencora Inc (NYSE:COR), Cardinal Health Inc (NYSE:CAH), Henry Schein Inc (NASDAQ:HSIC) and AdaptHealth Corp (NASDAQ:AHCO).
Virax Biolabs Group has a consensus price target of $25.00.
The stock price for Virax Biolabs Group (NASDAQ: VRAX) is $1.33 last updated October 30, 2026 at 9:29 AM EDT.
There are no upcoming dividends for Virax Biolabs Group.
Virax Biolabs Group does not have any upcoming earnings scheduled.
There is no upcoming split for Virax Biolabs Group.
Virax Biolabs Group is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on...
